Related Experiment Video
Updated: May 4, 2026

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Will therapies that target tumour suppressor genes be useful in cancer treatment?
Elwira Szychot1, Andrzej Brodkiewicz, Jarosław Peregud-Pogorzelski
1Hematology and Oncology Department, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
Abstract:
Human cancers represent one of the biggest challenges for modern societies. By 2020, cancer deaths worldwide could reach 10 million. Therefore, one of the important aims of science research is the improvement of anti-malignant treatment options to mitigate cancer-related morbidity and mortality. This essay summarises current trends and future directions of target tumour suppressor genes therapies based on an example of one of the most promising targets, p53.
Insights
Targeting tumor suppressor genes like p53 offers a promising strategy to improve anti-cancer treatments. Research focuses on enhancing therapies to reduce cancer morbidity and mortality, addressing a major global health challenge.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Human cancers pose a significant global health challenge, with projected mortality rates reaching 10 million by 2020.
- Effective anti-cancer treatments are crucial for mitigating cancer-related morbidity and mortality.
Purpose of the Study:
- To summarize current trends and future directions in targeting tumor suppressor genes for cancer therapy.
- To highlight the potential of p53 as a key therapeutic target.
Main Methods:
- Literature review of current research on tumor suppressor gene therapies.
- Analysis of the role of p53 in cancer and its therapeutic implications.
Main Results:
- Discussion of emerging strategies in targeting tumor suppressor genes.
- Identification of p53 as a highly promising target for novel anti-cancer therapies.
Conclusions:
- Targeting tumor suppressor genes represents a vital area for advancing cancer treatment.
- Further research into p53-based therapies holds significant potential for improving patient outcomes.
More Related Videos
07:48Utilizing Functional Genomics Screening to Identify Potentially Novel Drug Targets in Cancer Cell Spheroid Cultures
Published on: December 26, 2016
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targeted Cancer Therapies
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Loss of Tumor Suppressor Gene Functions